Results from a Phase 2b, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122/DNL151 in Participants with Early-Stage Parkinson&#39;s Disease

DNL151 - Denali Therap, Biogen

Sep 19, 2026